Biorestorative Therapies, Inc. current report, 27 May 2015

Business Context and Reporting Period

Company: Biorestorative Therapies, Inc.
Filing Type: Form 8-K (Current Report)
Date: May 27, 2015
Context: The filing discloses presentation materials intended for use at the Marcum Microcap Conference on May 27-28, 2015, and for other investor communications. The materials are furnished under Regulation FD and are not deemed "filed" for liability purposes under Section 18 of the Securities Exchange Act of 1934.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the existence and availability of presentation materials (Exhibit 99.1) rather than to report financial results.

Material Changes

No material changes to financial performance or operations are reported in this document. The filing is procedural, announcing the release of summary presentation materials to the public.

Guidance, Outlook, and Risks

  • Outlook: Management intends to use the presentation materials to discuss the Company's business with investors, lenders, and other stakeholders.
  • Forward-Looking Statements: The Company disclaims any obligation to update the presentation materials to reflect future events or circumstances occurring after May 27, 2015.
  • Availability: The materials are posted on the Company's Investor Relations website for 90 days.

Investor Verification Checklist

  • Verify the content of the "Presentation Materials" (Exhibit 99.1) referenced in this filing, as the 8-K itself contains no operational data.
  • Confirm the date of the presentation materials to ensure they reflect the most current information available, noting the Company's disclaimer regarding future updates.
  • Review the Company's website (www.biorestorative.com) for the posted materials within the 90-day window.